According to multiple sources, FDA is looking to reinstate staffers who were fired by the presidential administration last week, including at least ten people who are responsible for reviewing the safety of food ingredients. USDA is also working to rehire terminated employees responsible for avian influenza response.
According to Bloomberg,attorney Kyle Diamantas, J.D. is expected to replace former Deputy Commissioner for Human Foods Jim Jones at FDA following his resignation, which was precipitated by mass layoffs within FDA’s Human Foods Program.
The results of an FDA retail survey have been published, showing that pasteurization effectively inactivates avian influenza in dairy products other than milk, such as butter, ice cream, and cheese. USDA analyzed the samples collected by FDA.
Major public health, food industry, and consumer protection groups have stated concerns about the recent mass firing of FDA Human Foods Program staff and the resignation of Deputy Commissioner Jim Jones, expressing that layoffs could jeopardize food safety and HHS Secretary Robert F. Kennedy Jr.’s Make America Healthy Again (MAHA) agenda.
According to the National Environmental Health Association (NEHA), adoption of the most recent version of the FDA Food Code is increasing across the country at a record rate, reflecting a prioritization toward food safety.
In a February 17 resignation letter, James (Jim) Jones, FDA Deputy Commissioner for Human Foods, stated that 89 “indiscriminate” firings in the Human Foods Program, including layoffs of employees with “highly technical expertise in nutrition, infant formula, food safety response,” would render his job to protect food safety “fruitless.”
Changes are coming to the U.S. Department of Health and Human Services (HHS) with the recent confirmation of President Trump's nominee Robert F. Kennedy Jr. (RFK Jr.) as Secretary, amid talks of major workforce reductions at HHS agencies including FDA and CDC.
This article examines the health risks of PFAS migration from food packaging, and how food and beverage companies can go about phasing out their use to comply with U.S. Food and Drug Administration (FDA) regulations and state laws.
This article examines food recall trends for 2024, including USDA and FDA guidance expanding the scope of recalls and class action lawsuits filed in response to foodborne illness and recall events. The author discusses what these trends mean for industry, and if they are expected to continue into the future.
This article provides a regulatory perspective on some of the technical challenges that growing cannabis markets face, specifically focusing on product standardization, quality control testing, and consumer education and awareness amid a rapidly developing industry.